December 2014 Br J Cardiol 2014;21:158 doi:10.5837/bjc.2014.036
Debra E Irwin, Michelle Johnson, Simon Hogan, Mark Davies, Chris Arden
Introduction Atrial fibrillation (AF) is a supraventricular tachyarrhythmia characterised by uncoordinated activation of the atria. AF is a progressive disease and represents the most common serious disorder of cardiac rhythm. The incidence and prevalence of the disease increase progressively with age and is more common among men.1–5 AF is associated with higher mortality and cardiovascular (CV) morbidity.6–13 Specifically, AF is a recognised risk factor for stroke, with the proportion of strokes attributable to AF increasing exponentially with age.1,2,7,14–17 Although clinicians are most concerned about stroke risk among AF patients, c
July 2014 Br J Cardiol 2014;21:91–3 doi:10.5837/bjc.2014.021
Peter Sever, Judy Mackay
(more…)
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits